LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Akebia Therapeutics (NASDAQ: AKBA)

Follow NASDAQ:AKBA Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ AKBA Akebia Therapeutics
Ostrowski Erik / officer: SVP, CFO, CBO & Treasurer
06/30/2025
Sell
$3.67
41,314
$152K
503,586
NASDAQ AKBA Akebia Therapeutics
ZUMWALT LEANNE M / director
06/10/2025
Buy
$3.92
53,600
$210K
53,600
NASDAQ AKBA Akebia Therapeutics
ADAMS ADRIAN / director
06/10/2025
Buy
$3.92
53,600
$210K
53,600
NASDAQ AKBA Akebia Therapeutics
Wolf Myles / director
06/10/2025
Buy
$3.92
53,600
$210K
53,600
NASDAQ AKBA Akebia Therapeutics
Smith Cynthia / director
06/10/2025
Buy
$3.92
53,600
$210K
53,600
NASDAQ AKBA Akebia Therapeutics
ROGERS MICHAEL W / director
06/10/2025
Buy
$3.92
53,600
$210K
53,600
NASDAQ AKBA Akebia Therapeutics
GILMAN STEVEN C / director
06/10/2025
Buy
$3.92
53,600
$210K
53,600
NASDAQ AKBA Akebia Therapeutics
FRIESON RON / director
06/10/2025
Buy
$3.92
53,600
$210K
53,600
NASDAQ AKBA Akebia Therapeutics
Malabre Richard C / officer: SVP, Chief Accounting Officer
06/09/2025
Sell
$1.68
15,000
$25K
321,000
NASDAQ AKBA Akebia Therapeutics
Malabre Richard C / officer: SVP, Chief Accounting Officer
06/09/2025
Buy
$1.68
15,000
$25K
281,914
NASDAQ AKBA Akebia Therapeutics
Malabre Richard C / officer: SVP, Chief Accounting Officer
06/09/2025
Sell
$4.01
15,000
$60K
266,914
NASDAQ AKBA Akebia Therapeutics
Malabre Richard C / officer: SVP, Chief Accounting Officer
06/04/2025
Sell
$3.53
13,334
$47K
266,914

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous